Cipla - Milestones

Milestones

1935

Dr K A Hamied sets up "The Chemical, Industrial and Pharmaceutical

Laboratories Ltd." in a rented bungalow, at Bombay Central.

1941

As the Second World War cuts off drug supplies, the company starts

producing fine chemicals, dedicating all its facilities for the war effort.

1952

Sets up first research division for attaining self-sufficiency in technological

development.

1960

Starts operations at second plant at Vikhroli, Mumbai, producing fine

chemicals with special emphasis on natural products.

1968

Cipla manufactures ampicillin for the first time in the country.

1972

Starts Agricultural Research Division at Bangalore, for scientific cultivation

of medicinal plants.

1976

Cipla launches medicinal aerosols for asthma.

1980

Wins Chemexcil Award for Excellence for exports.

http://www.cipla.com/corporateprofile/milestones.htm (1 of 3)1/31/2011 3:12:07 PM

Cipla - Milestones

1982

Fourth factory begins operations at Patalganga, Maharashtra.

1984

Develops anti-cancer drugs, vinblastine and vincristine in collaboration with

the National Chemical Laboratory, Pune. Wins Sir P C Ray Award for

developing inhouse technology for indigenous manufacture of a number of

basic drugs.

1985

US FDA approves Cipla's bulk drug manufacturing facilities.

1988

Cipla wins National Award for Successful Commercialisation of Publicly

Funded R&D.

1991

Lauches etoposide, a breakthrough in cancer chemotherapy, in association

with Indian Institute of Chemical Technology.

The company pioneers the manufacture of the antiretroviral drug,

zidovudine, in technological collaboration with Indian Institute of Chemical

Technology, Hyderabad.

1994

Cipla's fifth factory begins commercial production at Kurkumbh,

Maharashtra.

1997

Launches transparent Rotahaler, the world's first such dry powder inhaler

device now patented by Cipla in India and abroad. The palliative cancer

care centre set up by the Cipla Foundation, begins offering free services at

Warje, near Pune.

1998

Launches lamivudine, becoming one of the few companies in the world to

offer all three component drugs of retroviral combination therapy

(zidovudine and stavudine already launched).

http://www.cipla.com/corporateprofile/milestones.htm (2 of 3)1/31/2011 3:12:07 PM

Cipla - Milestones

1999

Launches Nevirapine, antiretroviral drug, used to prevent the transmission

of AIDS from mother to child.

2000

Cipla became the first company, outside the USA and Europe to launch CFC-

free inhalers – ten years before the deadline to phase out use of CFC in

medicinal products.

2002

Four state-of-the-art manufacturing facilities set up in Goa in a record time

of less than twelve months.

2003

Launches TIOVA (Tiotropium bromide), a novel inhaled, long-acting

anticholinergic bronchodilator that is employed as a once-daily

maintenance treatment for patients with chronic obstructive pulmonary

disease (COPD).

Commissioned second phase of manufacturing operations at Goa.

2005

Set-up state-of-the-art facility for manufacture of formulations at Baddi,

Himachal Pradesh.

2007

Set-up state-of-the-art facility for manufacture of formulations at Sikkim.

2010

Set up state-of-the-art facility for manufacture of formulations at Indore.

Home l Corporate Profile l Our Products l Doctors Section l Whats New l Global Presence l Contact

Us l Search l Sitemap l Disclaimer

http://www.cipla.com/corporateprofile/milestones.htm (3 of 3)1/31/2011 3:12:07 PM